Inventor
GOLDFINGER VALENTINA
DE31 patents
⚠️ This page may combine multiple inventors who share the name “GOLDFINGER VALENTINA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
IMMATICS BIOTECHNOLOGIES GMBH
29 patentsUS10253077B2Apr 9, 2019
Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
IMMATICS BIOTECHNOLOGIES GMBH94 citations99
US10449238B2Oct 22, 2019
Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
IMMATICS BIOTECHNOLOGIES GMBH18 citations98
US10377802B2Aug 13, 2019
Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
IMMATICS BIOTECHNOLOGIES GMBH83 citations98
US10383930B2Aug 20, 2019
Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
IMMATICS BIOTECHNOLOGIES GMBH16 citations97
US11826409B2Nov 28, 2023
Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
IMMATICS BIOTECHNOLOGIES GMBH6 citations94
US11065315B2Jul 20, 2021
Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
IMMATICS BIOTECHNOLOGIES GMBH12 citations94
US11058754B2Jul 13, 2021
Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
IMMATICS BIOTECHNOLOGIES GMBH14 citations94
US10799569B2Oct 13, 2020
Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
IMMATICS BIOTECHNOLOGIES GMBH14 citations94
US10654904B2May 19, 2020
Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
IMMATICS BIOTECHNOLOGIES GMBH20 citations94
US10597432B2Mar 24, 2020
Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
IMMATICS BIOTECHNOLOGIES GMBH17 citations94
US10532091B1Jan 14, 2020
Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
IMMATICS BIOTECHNOLOGIES GMBH14 citations94
US10487126B2Nov 26, 2019
Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
IMMATICS BIOTECHNOLOGIES GMBH17 citations94
US10478480B2Nov 19, 2019
Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
IMMATICS BIOTECHNOLOGIES GMBH14 citations94
US10376568B2Aug 13, 2019
Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
IMMATICS BIOTECHNOLOGIES GMBH14 citations94
US10155032B2Dec 18, 2018
Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
IMMATICS BIOTECHNOLOGIES GMBH12 citations93
US9993539B2Jun 12, 2018
Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
IMMATICS BIOTECHNOLOGIES GMBH13 citations93
US10238727B2Mar 26, 2019
Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
IMMATICS BIOTECHNOLOGIES GMBH13 citations92
US11786584B2Oct 17, 2023
Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
IMMATICS BIOTECHNOLOGIES GMBH4 citations86
US12180259B2Dec 31, 2024
Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations73
US12144852B2Nov 19, 2024
Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations73
US12102670B2Oct 1, 2024
Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations73
US12097249B2Sep 24, 2024
Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations73
US12076381B2Sep 3, 2024
Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations73
US11111280B2Sep 7, 2021
Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
IMMATICS BIOTECHNOLOGIES GMBH1 citations73
US10654903B2May 19, 2020
Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
IMMATICS BIOTECHNOLOGIES GMBH2 citations73
US10597433B2Mar 24, 2020
Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
IMMATICS BIOTECHNOLOGIES GMBH1 citations73
US12173043B2Dec 24, 2024
Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations63
US11905319B2Feb 20, 2024
Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations63
US10899806B2Jan 26, 2021
Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations63
immatics biotechnology GmbH
2 patentsUS10500259B2Dec 10, 2019
Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
immatics biotechnology GmbH17 citations96
US9908920B2Mar 6, 2018
Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
immatics biotechnology GmbH15 citations95